Marrone Bio Innovations Receives Patent for Use of Chromobacterium to Control Corn Rootworm Larvae Infestation

September 11, 2014, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that it has received a patent for the use of Chromobacterium, a naturally occurring bacterium with demonstrated insecticidal and miticidal capabilities. The patent protects the uses of Chromobacterium formulations, compositions and compounds to control corn rootworm larvae infestation. more »

Scott Peoples Joins Marrone Bio Innovations as Vice President of Marketing

Peoples to drive demand creation of MBI’s suite of bio-based pest management and plant health products

MBI_Peoples_Scott_9470_R_W small (1)

September 09, 2014, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that Scott Peoples has joined the company as its Vice President of Marketing.  In this role, Peoples will be responsible for driving demand creation of MBI’s suite of products to farmers and growers across the agriculture industry. He will also provide leadership in product management and business development activities.

“We are pleased to welcome Scott to MBI’s senior management as he will play a critical role in driving demand and penetration of our bio-based products, that promote plant health and control unwanted pests in agriculture and water,” said Pam Marrone, Chief Executive Officer of Marrone Bio Innovations.  “The global market for bio-based agricultural solutions remains early in its growth curve and MBI is well-positioned to capitalize on this growth with our strengthened management team, our growing suite of effective and environmentally responsible products, new collaborations and partnerships, and our growing pipeline of new business opportunities.”

A 19 year veteran of the agriculture industry with 29 years of business experience, Peoples joins MBI from BASF where he served in several roles, including marketing manager, business development manager, global strategic marketing manager and most recently, Senior Global Business Manager for Herbicide Tolerance.  Prior to BASF, Peoples held several positions at Monsanto, including field representative, and marketing and business manager of a Monsanto subsidiary focused on application equipment.  Prior to his time in the agriculture industry, he spent nearly 10 years in the laboratory robotics industry with DuPont, Tecan, and as a founder of Leap Technologies.  Peoples has a chemistry degree with a minor in biology from the University of Delaware, and an MBA from the University of North Carolina, Chapel Hill Executive program.

 ****

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to market size and the results from the field trials.  Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-K that the Company filed with the Securities and Exchange Commission on March 25, 2014.

Marrone Bio Innovations Announces Registration of Bioinsecticide VENERATETM In California

Multiple modes of action, MRL tolerance exemption, and favorable environmental profile combine to deliver a powerful new tool for fruit, nut, vine and vegetable growers

Logo_Venerate_280DAVIS, Calif., August 27, 2014 — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its VENERATETM Bioinsecticide is now registered in California.  VENERATE is a new tool to help California growers control crop-damaging insect pests, fight the development of insect resistance and reduce pesticide residues on fruits and vegetables. more »

Marrone Bio Innovations Announces Date for Second Quarter 2014 Financial Results

DAVIS, Calif., July 29, 2014 —Marrone Bio Innovations, Inc. (NASDAQ: MBII), a provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that it will release its earnings results for the second quarter ended June 30, 2014 on Thursday, August 7, 2014 after the market closes.

>> Link to full announcement

Evogene and Marrone Bio Innovations Sign Multi-Year Collaborative Agreement

Joint Discovery Efforts to Lead to Novel Insect Control Solutions

Evogene_MBI
REHOVOT, Israel and DAVIS, California – July  22, 2014 – Evogene Ltd. (NYSE; TASE: EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, and Marrone Bio Innovations Inc. (MBI), (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, announced today the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the companies.   more »

Marrone Bio Innovations Appoints George Kerckhove to its Board of Directors

george-kerckhove

DAVIS, Calif., July 14, 2014 — Marrone Bio Innovations, Inc. (MBI)[NASDAQ: MBII], a leading global provider of bio-based pest management and plant health products is pleased to announce the appointment of George Kerckhove to its Board of Directors.

Mr Kerckhove’s most recent professional experience included over 12 years with American Standard Companies, where he served as VP and Chief Financial Officer, Executive VP and Global Sector Manager of 21 countries and President and General Manager of the European Division. Prior to that, he served in a variety of positions over a 25 year tenure with The Trane Company in LaCrosse, WI, from Product Manager to VP and General Manager of the Process Equipment Division, and finally Executive VP and General Manager of both the US and International Commercial Equipment Divisions. more »

BIRD – Israel-U.S. Binational Industrial R&D Foundation to Invest $9 Million in 11 New Projects

The approved projects involve innovations in the areas of 3D Printing, Agro-technology, Information Security, Homeland Security and others

TEL AVIV, Israel, July 8, 2014 /PRNewswire/ –

During its meeting on June 26, 2014, held in Washington D.C., the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation, approved $8.9 million in funding for eleven new projects between Israeli and American companies. In addition to the grants from BIRD, the projects will access private sector funding, boosting the total value of all projects to approximately $25 million.

The BIRD Foundation promotes collaboration between Israeli and American companies in various technological fields for the purpose of joint product development. In addition to providing conditional grants of up to $1 million for approved projects, the Foundation assists by working with companies to identify potential strategic partners and facilitate introductions. more »

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. ...
  10. 35